DE69507339T2 - Polymer-mikrokugeln und verfahren zu deren herstellung - Google Patents
Polymer-mikrokugeln und verfahren zu deren herstellungInfo
- Publication number
- DE69507339T2 DE69507339T2 DE69507339T DE69507339T DE69507339T2 DE 69507339 T2 DE69507339 T2 DE 69507339T2 DE 69507339 T DE69507339 T DE 69507339T DE 69507339 T DE69507339 T DE 69507339T DE 69507339 T2 DE69507339 T2 DE 69507339T2
- Authority
- DE
- Germany
- Prior art keywords
- water
- soluble polymer
- pct
- polymer
- microspheres
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/005—Processes for mixing polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
- C08J3/126—Polymer particles coated by polymer, e.g. core shell structures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2989—Microcapsule with solid core [includes liposome]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
- Y10T428/2998—Coated including synthetic resin or polymer
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9406094A GB9406094D0 (en) | 1994-03-28 | 1994-03-28 | Polymer microspheres and a method of production thereof |
PCT/GB1995/000686 WO1995026376A2 (en) | 1994-03-28 | 1995-03-27 | Polymer microspheres and a method of production thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69507339D1 DE69507339D1 (de) | 1999-02-25 |
DE69507339T2 true DE69507339T2 (de) | 1999-08-26 |
Family
ID=10752618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69507339T Expired - Fee Related DE69507339T2 (de) | 1994-03-28 | 1995-03-27 | Polymer-mikrokugeln und verfahren zu deren herstellung |
Country Status (7)
Country | Link |
---|---|
US (1) | US5922357A (de) |
EP (1) | EP0797615B1 (de) |
JP (1) | JPH09511002A (de) |
AT (1) | ATE175699T1 (de) |
DE (1) | DE69507339T2 (de) |
GB (1) | GB9406094D0 (de) |
WO (1) | WO1995026376A2 (de) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL110787A0 (en) | 1993-08-27 | 1994-11-11 | Sandoz Ag | Biodegradable polymer, its preparation and pharmaceutical composition containing it |
DE19545257A1 (de) | 1995-11-24 | 1997-06-19 | Schering Ag | Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln |
US6730735B2 (en) | 1997-07-03 | 2004-05-04 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Conjugate of polyethylene glycol and chitosan |
DE19745950A1 (de) * | 1997-10-17 | 1999-04-22 | Dds Drug Delivery Service Ges | Arzneistoffträgerpartikel für die gewebespezifische Arzneistoffapplikation |
US20030180368A1 (en) * | 1998-03-14 | 2003-09-25 | Cenes Drug Delivery Limited | Production of microparticles |
IL139030A0 (en) * | 1998-04-17 | 2001-11-25 | Angiogenix Inc | Therapeutic angiogenic factors and methods for their use |
US6270806B1 (en) * | 1999-03-03 | 2001-08-07 | Elan Pharma International Limited | Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions |
CA2337187C (en) * | 1999-05-29 | 2011-02-22 | Guanghui Zhang | Bioabsorbable blends and surgical articles therefrom |
ES2292634T3 (es) | 2000-12-21 | 2008-03-16 | Alrise Biosystems Gmbh | Procedimiento de transicion de fase inducida para la produccion de microparticulas que contienen agentes hidrofilos activos. |
US20040126900A1 (en) * | 2001-04-13 | 2004-07-01 | Barry Stephen E | High affinity peptide- containing nanoparticles |
US7713932B2 (en) | 2001-06-04 | 2010-05-11 | Biocon Limited | Calcitonin drug-oligomer conjugates, and uses thereof |
US6828297B2 (en) | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US6713452B2 (en) | 2001-06-04 | 2004-03-30 | Nobex Corporation | Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US6835802B2 (en) | 2001-06-04 | 2004-12-28 | Nobex Corporation | Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties |
US6828305B2 (en) | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
CO5390081A1 (es) * | 2001-11-28 | 2004-04-30 | Novartis Ag | Compuestos organicos |
JP2005513145A (ja) * | 2001-12-21 | 2005-05-12 | セラター テクノロジーズ インコーポレイテッド | 改変されたポリマー脂質送達ビヒクル |
AU2003272284B2 (en) * | 2002-09-05 | 2009-03-05 | Catherine G. Ambrose | Antibiotic microspheres for treatment of infections and osteomyelitis |
US8986737B2 (en) * | 2002-09-05 | 2015-03-24 | Wm. Marsh Rice University | Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth |
US6938589B2 (en) * | 2002-11-07 | 2005-09-06 | Powervantage Engines, Inc. | Variable displacement engine |
GB2407500A (en) * | 2003-11-03 | 2005-05-04 | Ist Superiore Sanita | Use of microparticles for antigen delivery |
EP1701751B1 (de) * | 2003-11-14 | 2011-12-21 | Interventional Therapies, LLC | Verbesserte zwinge |
US7875700B2 (en) | 2004-07-19 | 2011-01-25 | Biocon Limited | Cation complexes of insulin compound conjugates, formulation and uses thereof |
US7405002B2 (en) * | 2004-08-04 | 2008-07-29 | Agency For Science, Technology And Research | Coated water-soluble nanoparticles comprising semiconductor core and silica coating |
US7534489B2 (en) * | 2004-09-24 | 2009-05-19 | Agency For Science, Technology And Research | Coated composites of magnetic material and quantum dots |
KR100665672B1 (ko) * | 2005-04-13 | 2007-01-09 | 성균관대학교산학협력단 | 새로운 온도 및 pH 민감성 블록 공중합체 및 이를 이용한고분자 하이드로겔 |
US8663686B2 (en) | 2005-05-09 | 2014-03-04 | University Of Washington | Biodegradable chitosan-PEG compositions and methods of use |
WO2007007403A1 (ja) * | 2005-07-13 | 2007-01-18 | Miyoshi Kasei, Inc. | 表面処理粉体及びこれを含有する化粧料 |
CN101283025B (zh) | 2005-10-27 | 2014-12-10 | 东丽株式会社 | 生物降解性粒子及其制造方法 |
US8021689B2 (en) * | 2006-02-21 | 2011-09-20 | Ecole Polytechnique Federale de Lausanne (“EPFL”) | Nanoparticles for immunotherapy |
GB0701896D0 (en) * | 2007-02-01 | 2007-03-14 | Regentec Ltd | Composition |
JP2010517638A (ja) * | 2007-02-02 | 2010-05-27 | トアニエ, インコーポレイテッド | 腱および靱帯を修復するシステムおよび方法 |
KR101529894B1 (ko) * | 2007-08-21 | 2015-06-18 | 더 리전츠 오브 더 유니버시티 오브 캘리포니아 | 코폴리머-안정화된 에멀션 |
MX2010003979A (es) | 2007-10-16 | 2010-06-02 | Biocon Ltd | Composicion farmaceutica oralmente administrable y proceso para su preparacion. |
WO2009085952A1 (en) | 2007-12-20 | 2009-07-09 | Brookwood Pharmaceuticals, Inc. | Process for preparing microparticles having a low residual solvent volume |
EP2285901B1 (de) | 2008-05-06 | 2020-07-22 | CJ CheilJedang Corporation | Biologisch abbaubare polyestermischungen |
EP2376060B1 (de) * | 2008-12-15 | 2012-09-19 | Novartis AG | Nanopartikelzusammensetzungen |
AU2009329820B2 (en) * | 2008-12-22 | 2012-12-06 | The University Of Melbourne | Method for controlling water evaporation |
EP4008355A1 (de) | 2012-05-03 | 2022-06-08 | Kala Pharmaceuticals, Inc. | Pharmazeutische nanopartikel mit verbessertem mukosalem transport |
US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
EP3808339A1 (de) | 2012-05-03 | 2021-04-21 | Kala Pharmaceuticals, Inc. | Pharmazeutische nanopartikel mit verbessertem mukosalem transport |
US9475930B2 (en) | 2012-08-17 | 2016-10-25 | Metabolix, Inc. | Biobased rubber modifiers for polymer blends |
US9353122B2 (en) | 2013-02-15 | 2016-05-31 | Kala Pharmaceuticals, Inc. | Therapeutic compounds and uses thereof |
ES2831625T3 (es) | 2013-02-20 | 2021-06-09 | Kala Pharmaceuticals Inc | Compuestos terapéuticos y sus usos |
US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
EP3004225A1 (de) | 2013-05-30 | 2016-04-13 | Metabolix, Inc. | Rezyklatmischungen |
CA2923753C (en) | 2013-09-19 | 2021-10-12 | Terumo Corporation | Polymer particles |
AU2014321278B2 (en) | 2013-09-19 | 2016-11-10 | Microvention, Inc. | Polymer films |
US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
AU2014342042B2 (en) | 2013-11-01 | 2017-08-17 | KALA BIO, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
AU2014346486B2 (en) | 2013-11-08 | 2016-12-08 | Terumo Corporation | Polymer particles |
US10611903B2 (en) | 2014-03-27 | 2020-04-07 | Cj Cheiljedang Corporation | Highly filled polymer systems |
WO2016154592A1 (en) | 2015-03-26 | 2016-09-29 | Microvention, Inc. | Embiolic particles |
US10392399B2 (en) | 2016-09-08 | 2019-08-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
EP3509421A4 (de) | 2016-09-08 | 2020-05-20 | Kala Pharmaceuticals, Inc. | Kristalline formen therapeutischer verbindungen und verwendungen davon |
US10253036B2 (en) | 2016-09-08 | 2019-04-09 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
US10201632B2 (en) | 2016-09-28 | 2019-02-12 | Terumo Corporation | Polymer particles |
CA3119291A1 (en) * | 2018-11-13 | 2020-05-22 | Arysta Lifescience Inc. | Encapsulation of cyclohexanediones process and product |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4581337A (en) * | 1983-07-07 | 1986-04-08 | E. I. Du Pont De Nemours And Company | Polyether polyamines as linking agents for particle reagents useful in immunoassays |
FR2615194B1 (fr) * | 1987-05-11 | 1991-06-14 | Rhone Poulenc Chimie | Particules de polymere comportant, implantees a leur surface des molecules amphiphiles portant des groupes ionogenes ou reactifs, leur procede de preparation et leur application en biologie |
US5545823A (en) * | 1991-06-11 | 1996-08-13 | Yung Chi Paint & Varnish Mfg. Co., Ltd. | Self-polishing type antifouling coating composition containing film-formable metal soap compound |
US5565215A (en) * | 1993-07-23 | 1996-10-15 | Massachusettes Institute Of Technology | Biodegradable injectable particles for imaging |
US5468526A (en) * | 1993-09-20 | 1995-11-21 | The Dow Chemical Company | Multilayer barrier film for ostomy applications |
US5612052A (en) * | 1995-04-13 | 1997-03-18 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
US5795864A (en) * | 1995-06-27 | 1998-08-18 | Neurex Corporation | Stable omega conopetide formulations |
-
1994
- 1994-03-28 GB GB9406094A patent/GB9406094D0/en active Pending
-
1995
- 1995-03-27 WO PCT/GB1995/000686 patent/WO1995026376A2/en active IP Right Grant
- 1995-03-27 EP EP95912372A patent/EP0797615B1/de not_active Expired - Lifetime
- 1995-03-27 US US08/714,081 patent/US5922357A/en not_active Expired - Fee Related
- 1995-03-27 JP JP7525042A patent/JPH09511002A/ja not_active Ceased
- 1995-03-27 AT AT95912372T patent/ATE175699T1/de not_active IP Right Cessation
- 1995-03-27 DE DE69507339T patent/DE69507339T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB9406094D0 (en) | 1994-05-18 |
EP0797615B1 (de) | 1999-01-13 |
EP0797615A2 (de) | 1997-10-01 |
JPH09511002A (ja) | 1997-11-04 |
DE69507339D1 (de) | 1999-02-25 |
ATE175699T1 (de) | 1999-01-15 |
WO1995026376A3 (en) | 1995-11-16 |
US5922357A (en) | 1999-07-13 |
WO1995026376A2 (en) | 1995-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69507339D1 (de) | Polymer-mikrokugeln und verfahren zu deren herstellung | |
Bader et al. | Watersoluble polymers in medicine | |
Kowalczuk et al. | Loading of polymer nanocarriers: Factors, mechanisms and applications | |
DE69327490T2 (de) | Arzneimittel aus Polymer-Micellen mit physikalischer Einschlusswirkung | |
DE69534780T2 (de) | Flüssige Zusammensetzungen zur Arzneistoffabgabe | |
JP5502751B2 (ja) | 低残留溶媒濃度を有する微粒子を調製するためのプロセス | |
DE69735435T2 (de) | Ester-terminierte polyamidgele | |
ATE141788T1 (de) | Mikrosphäre enthaltende pharmazeutische zusammensetzung mit kontrollierter freigabe und verfahren zur herstellung | |
DE3913734C2 (de) | Verwendung einer wäßrigen Hauthaftkleberlösung zur Herstellung einer mit Wasser leicht abwaschbaren Klebschicht | |
JPH10512287A (ja) | 生分解性高分子ミセル−タイプ薬物組成物およびその製造方法 | |
GB2273657B (en) | Preparation of solid microspheres or air-filled microcapsules | |
DE69509671T2 (de) | Pharmazeutische zusammensetzung mit einem schmelzbaren traegermaterial und verfahren zu seiner herstellung | |
BRPI9711856B8 (pt) | métodos para preparação de um agente ativo, substancialmente insolúvel em água e composição para liberação in vivo de um agente ativo | |
JP2000191505A (ja) | 水―分散性アニオン性ポリマ―を主体とするナノカプセル、その製造方法及びそれを含む化粧品又は皮膚用組成物 | |
CA2430481A1 (en) | Compositions for sustained delivery of hydrophobic drugs and process for the preparation thereof | |
WO2004035923A3 (en) | Tissue paper softening compositions and tissue papers comprising the same | |
JPH0657005A (ja) | ナノカプセルあるいはナノ粒子の分散コロイダル系の連続製造方法 | |
WO2003020824A1 (de) | Gelmatrix aus polyacrylsäure und polyvinylpyrrolidon | |
DE69828513D1 (de) | Verfahren zur herstellung von nanokapseln des vesikulären typs | |
CA2187898A1 (fr) | Microspheres biodegradables a liberation controlee et leur procede de preparation | |
BR9915462A (pt) | Processos para preparação de partìculas dedroga revestidas e as suas formulaçõesfarmacêuticas | |
KR970704428A (ko) | 활성성분의 선택적 방출을 제공하는 합성물(composition providing selective release of an active ingredient) | |
DE10215858A1 (de) | Verfahren zur Haarbehandlung mit Formgedächtnispolymeren | |
DE69924829T2 (de) | Zusammensetzungen, die ein Polykondensat mit mindestens einer Polyurethan- und/oder Polyharnstoffeinheit und ein Silicon mit mindestens einer Carboxyfunktion enthalten | |
ATE258794T1 (de) | Ein chinolonderivat enthaltendes arzneimittel und verfahren zu dessen herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |